Gepirone

CHEMBL284092 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

359.5 g/mol

LogP

1.8

Phase

4

This partial agonist at serotonin 5-HT1A receptors is used to treat generalized anxiety disorder and major depressive disorder.

Berat Molekul

359,5000 g/mol

LogP

1,80

TPSA

69,60 Å²

Lipinski RO5

Lulus

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1

InChI

InChI=1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3

Molecular Formula

C19H29N5O2

HBD / HBA

- / 6

Ikatan yang Dapat Dirotasi

6

Atom Berat

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This partial agonist at serotonin 5-HT1A receptors is used to treat generalized anxiety disorder and major depressive disorder.

Yes, Gepirone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL284092. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 55191. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Mencari informasi yang ramah bagi pasien?

Gepirone di PillFYI

Struktur

Data Cepat

Rumus: C19H29N5O2
Sinonim: 1

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.